The FDA has given the approval for Bydureon, which is the first weekly treatment for Type 2 Diabetes.
The drug, an injection, is actually a long-acting form of Byetta. This shot can be used in combination with diet and exercise to improve blood sugar control among people with Type 2 diabetes.
Diabetes
A comprehensive article on diabetes - both Type 1 and Type 2 diabetes, including : causes, signs, symptoms, diagnosis, treatment, facts and a glossary on diabetes.
Advertisement
Bydureon, is manufactured by Alkermes PLC and Amylin Pharmaceuticals Inc. Initially the FDA had not approved this drug as there were concerns that it might increase the risk of heart problems. As part of the new approval, the FDA has asked the organization to conduct a study to gauge whether the drug actually elevates risk of heart disease.
John Buse, MD, PhD, professor of medicine, director of the Diabetes Care Center, and chief of the division of endocrinology at the University Of North Carolina School Of Medicine in Chapel Hill said, "With Bydureon, U.S. physicians and patients can now choose a therapy that offers continuous blood sugar control in just one dose per week."
Source: Medindia
Source: Medindia
Diabetes and Exercise
Regular exercise especially in type II diabetes not only helps reduce the sugar but also reduces the demand for medication by 20% and helps you stay healthy.
Advertisement
 Diabetes Diet PlanDiet plays a significant role in controlling diabetes. Most cases of diabetes are preventable with healthy lifestyle changes. | Advertisement
|
Advertisement
Recommended Readings
Latest Diabetes News
Recent study underscores tirzepatide's supremacy over semaglutide in regulating blood sugar and achieving weight loss.
Physical activity or exercise in the morning and afternoon reduces type 2 diabetes risk, whereas evening exercise has no such association.
Late sleepers and late risers may both have a higher risk of developing diabetes.
Semaglutide, the anti-diabetic drug operating by stimulating insulin secretion, might have the potential to supplant the need for mealtime insulin injections.
The gut bacteria known as Lachnospiraceae might have the ability to boost insulin sensitivity, potentially providing a protective barrier against diabetes.
